CHDI FOUNDATION, INC.
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 2003-01-01
- Employees
- 51
- Market Cap
- -
Clinical Trials
12
Trial Phases
1 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials
iMagemHTT- 009- FIH Evaluation of Novel Mutant Huntingtin PET Radioligand [11C]CHDI-00491009
- Conditions
- Huntington DiseaseHDPET TracerPositron Emission TomographyRadioligandImagingmHTTHuntington'sHuntington's Disease
- First Posted Date
- 2024-10-10
- Last Posted Date
- 2024-10-10
- Lead Sponsor
- CHDI Foundation, Inc.
- Target Recruit Count
- 27
- Registration Number
- NCT06634628
- Locations
- 🇧🇪
Universitaire Ziekenhuizen Leuven/ UZ Leuven/ UZL, Leuven, Belgium
Natural History Study in Huntington Disease Gene Expansion Carriers (HDGECs) - SHIELD HD
- Conditions
- Huntington Disease
- First Posted Date
- 2020-05-28
- Last Posted Date
- 2022-09-23
- Lead Sponsor
- CHDI Foundation, Inc.
- Target Recruit Count
- 70
- Registration Number
- NCT04406636
- Locations
- 🇺🇸
University of California, San Diego (UCSD), San Diego, California, United States
🇺🇸Rocky Mountain Movement Disorders Center, Englewood, Colorado, United States
🇺🇸Beth Israel Deaconess, Boston, Massachusetts, United States
Development of Assessments for Later Stage HD
- Conditions
- Huntington Disease
- First Posted Date
- 2020-05-01
- Last Posted Date
- 2020-05-01
- Lead Sponsor
- CHDI Foundation, Inc.
- Target Recruit Count
- 340
- Registration Number
- NCT04370470
- Locations
- 🇺🇸
The Board of Trustees of the University of Alabama for the University of Alabama at Birmingham, Birmingham, Alabama, United States
🇺🇸Regents of the University of California, San Diego, La Jolla, California, United States
🇺🇸Regents of the University of California, Los Angeles, Los Angeles, California, United States
iMagemHTT: FIH Evaluation of Novel Mutant Huntingtin PET Radioligands [¹¹C]CHDI-00485180-R and [¹¹C]CHDI-00485626
- Conditions
- Huntington Disease
- First Posted Date
- 2019-01-22
- Last Posted Date
- 2023-05-06
- Lead Sponsor
- CHDI Foundation, Inc.
- Target Recruit Count
- 24
- Registration Number
- NCT03810898
- Locations
- 🇧🇪
Universitaire Ziekenhuizen Leuven/ UZ Leuven/ UZL, Leuven, Belgium
FuRST 2.0 Cognitive Pre-testing - Round 2
- Conditions
- Huntington Disease
- First Posted Date
- 2018-10-17
- Last Posted Date
- 2019-10-29
- Lead Sponsor
- CHDI Foundation, Inc.
- Target Recruit Count
- 52
- Registration Number
- NCT03709173
- Locations
- 🇺🇸
Rocky Mountain Movement Disorders Center, P.C., Englewood, Colorado, United States
🇺🇸Hereditary Neurological Disease Centre, Inc., Wichita, Kansas, United States
🇺🇸Columbia University, New York, New York, United States
- Prev
- 1
- 2
- 3
- Next